Neus Baste1 article listing Neus Baste in Nature Communications, indexed by Paperzzz from Crossref and OSF.Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial Nature Communications